Viewing Study NCT03145012


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2026-02-25 @ 3:07 AM
Study NCT ID: NCT03145012
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2017-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Sponsor: Nova Scotia Health Authority
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SAIL-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View